WEDNESDAY MAY 5

7 a.m.-8:30 a.m.

Industry-Supported Breakfast Symposia

IS50. PTSD: Searching for Answers in Traumatic Times (Part 1) Supported by Cephalon Inc.

  A. PTSD: Its Burden and the Toll From Terrorism Randall D. Marshall, M.D.

  B. Brain Imaging in PTSD: Going Beyond 5HT David J. Nutt, M.D.

  C. Sleep in PTSD and Other Anxiety Disorders Karl Doghramji, M.D.

IS51. Bipolar Disorder in Women: Reproductive Implications of Treatment (Part 1) Supported by GlaxoSmithKline

  A. Treatment of Bipolar Illness During Pregnancy Lee S. Cohen, M.D.

  B. Bipolar Illness During the Postpartum Period: Update on Treatment Adele C. Viguera, M.D.

  C. Treatment of Bipolar Illness in Adolescence: Implications for Younger Women Janet Wozniak, M.D.

7:30 a.m.-5 p.m.

Registration/Course Enrollment Open

8 a.m.-Noon

CME Courses 77-84

8 a.m.-5 p.m.

CME Course 85

9 a.m.-10:30 a.m.

Clinical Case Conference 3. Glenn J. Treisman, M.D., Andrew F. Angelino, M.D., and Heidi E. Hutton, Ph.D., on Psychiatric Issues in the Management of Patients With HIV Infection (Open to APA members only.)

Discussion Groups

18. Milton Viederman, M.D., on Psychological Engagement During the Consultation Process (Meet the Authors)

19. Geetha Jayaram, M.D., on Patient Safety (for residents only)

Lectures

L19. The Role of Glutamate in the Pathophysiology of Schizophrenia Joseph T. Coyle Jr., M.D., Distinguished Psychiatrist Lecture Series

L20. Latino Youth in the U.S.: Developmental and Mental Health Challenges Andres J. Pumariega, M.D., APA’s Simon Bolivar Award Lecture

Master Educator Clinical Consultations

8. Susan D. Block, M.D., on Psychiatric Issues and Interventions at the End of Life (Open to APA members only.)

9. Michael D. Garrett, M.D., on Can the Ordinary Mind Empathize With Psychotic Experiences? (Open to APA members only.)

Component Workshops

CW33. Terrorism in America: The Distant Victims and the Role of IMG Psychiatrists APA Committee on International Medical Graduates; Co-Chairpersons: Fructuoso R. Irigoyen-Rascon, M.D., Godehard Oepen, M.D.

CW34. CPT Coding and Documentation Update APA Committee on RBRVS, Codes, and Reimbursements; Chairperson: Chester W. Schmidt Jr., M.D.

CW35. The Psychiatrist in the Schools: Medication, Boundaries, and Transference Issues APA Corresponding Committee on Mental Health and Schools; Chairperson: Eugenio M. Rothe, M.D.

CW36. Taking the First Step: What Are My Options in the Transition to Practice? APA Assembly Committee of Early Career Psychiatrists; Chairperson: Murali Gopal, M.D.

CW37. APA Ethics Procedures APA Ethics Appeal Board; Chairperson: Wade C. Myers, M.D.

CW38. Dollars: The Pharmaceutical Industry in Psychiatric Training APA Committee of Residents and Fellows; Co-Chairpersons: William C. Wood, M.D., Geoffrey M. Hopkins, M.D.

CW39. Reducing Disparities in Access to Psychiatric Care: APA Perspectives APA Steering Committee to Reduce Disparities in Access to Psychiatric Care; Co-Chairpersons: Altha J. Stewart, M.D., Roger Dale. Walker, M.D.

CW40. New Classification of Psychopathology of Infants and Young Children APA Corresponding Committee on Infancy and Early Childhood; Chairperson: Irene Chatoor, M.D.

CW41. Consultation and Legal Clarification in Sexual Harassment APA New Jersey Psychiatric Association; Co-Chairpersons: Rita R. Newman, M.D., Annette J. Hollander, M.D.

Issue Workshops

IW77. Mirror, Mirror on the Wall: Ambition and the Teaching Psychiatrist Association for Academic Psychiatry; Co-Chairpersons: Susan Lieff, M.D., Philip R. Muskin, M.D.

IW78. The Trauma of Medical Mistakes: An Experiential Workshop Co-Chairpersons: Michael F. Myers, M.D., Leah J. Dickstein, M.D.

IW79. The Portrayal of ECT on Television, Film, and the Internet Chairperson: Patrick Ying, M.D.

IW80. Psychodynamic Treatment of Depression Chairperson: Fredric N. Busch, M.D.

IW81. When Usual Treatments Fail: Antipsychotic Strategies for Refractory Schizophrenia Chairperson: Jean-Pierre Lindenmayer, M.D.

IW82. Treatment of Patients With Drug Dependence and Psychiatric Illness Collaborative Session With the National Institute on Drug Abuse; Co-Chairpersons: Wilson Compton III, M.D., Roger D. Weiss, M.D.

IW83. Kundalini Yoga Meditation Techniques for Psychiatric Disorders Chairperson: David Shannahoff-Khalsa, B.A.

IW84. PTSD in the New York Fire Department: Bodies and Minds Chairperson: Kevin V. Kelly, M.D.

IW85. Women’s Mental Health in Times of Turmoil: An International Perspective Association of Women Psychiatrists; Chairperson: Sylvia W. Olarte, M.D.

IW86. Migration and Professional Identity Experience of Organizing Russian-American Psychiatry Chairperson: Nelly Katsnelson, M.D.

IW87. Vascular Dementia: Assessment, Imaging, and Treatment Chairperson: F. Moises Gaviria, M.D.

IW88. Medical Training for Psychiatrists: What Do We Need to Know? Chairperson: Peter Manu, M.D.

IW89. The Sissy Duckling: The Perils of Childhood Gender Variance Co-Chairpersons: Edgardo J. Menvielle, M.D., Catherine Tuerk, R.N.

IW90. Geriatric Psychiatry Around the Globe: Present and Future Chairperson: Dilip V. Jeste, M.D.

IW91. Premarital Counseling: The Facts of Life and More Chairperson: Lawrence Bryskin, M.D.

IW92. Psychotherapy Issues Throughout the Life Cycle in Asian Women Chairperson: Albert C. Gaw, M.D.

IW93. Practical Management of Mood Disorders Co-Chairpersons: Gary E. Miller, M.D., Richard L. Noel, M.D.

IW94. Dissolving Therapeutic Barriers: Spirituality Group Work With Psychiatric Staff Chairperson: C. Paul Yang, M.D.

IW95. Guideline Development for the Assessment of Competency Chairperson: Thomas S. Zaubler, M.D.

IW96. Innovations in Academic Emergency Psychiatry Co-Chairpersons: William R. Dubin, M.D., Henry W. Weisman, M.D.

IW97. Addiction Psychiatry: Science, Craft, and Spirituality Chairperson: Richard J. Frances, M.D.

IW98. Understanding and Treating Compulsive Sexual Behavior Chairperson: Eric Hollander, M.D.

IW99. Kendra’s Law Becomes Reality: Assisted Outpatient Treatment in Manhattan Co-Chairpersons: Andrew M. Kleiman, M.D., Gary R. Collins, M.D.

IW100. Sexual Satisfaction and Mental Health in Orthodox Jewish Women Co-Chairpersons: Rachel Yehuda, Ph.D., Michelle E. Friedman, M.D.

IW101. Treatment of Adult ADHD: Combining Cognitive and Medical Approaches Co-Chairpersons: Anthony L. Rostain, M.D., J. Russell Ramsay, Ph.D.

IW102. Implementing Psychosocial Treatments in Real-World Settings Chairperson: Edward Kim, M.D.

IW103. Criminal Justice System and Serious Mental Illness: Problems and Solutions Co-Chairpersons: Joseph R. Calabrese, M.D., Janet Berry, J.D.

9 a.m.-Noon

Continuous Clinical Case Conference 2. Stuart C. Yudofsky, M.D., Richard L. Munich, M.D., Efram Bleiberg , M.D., Lauren B. Marangell, M.D., Alice Rogan, M.D., and Florence Kim, M.D., on Two Hospitalized Patients With Refractory Mood Disorder and Cognitive Impairment (Part 1) (Open to APA members only.)

Media Workshops

MW5. Postgenocide Psychological Trauma in Film: “The Summer of Aviya” Co-Chairpersons: Maurice Preter, M.D., Harold J. Bursztajn, M.D.

MW6. The Beginning Stages of Couples’ Therapy: Video Case Studies Chairperson: Ian E. Alger, M.D.

9 a.m.-12:30 p.m.

Review of Psychiatry (Section 3): Developmental Psychobiology Chairperson: B.J. Casey, Ph.D.

11. Developmental Psychobiology: An Overview B.J. Casey, Ph.D.

12. Withdrawn

13. The Developmental Psychobiology of Early Attachment Myron Hofer, M.D.

14. The Developmental Neurobiology of Face Perception Charleston Nelson, M.D.

15. Developmental Psychobiology of Tourette’s Syndrome Kathy A. Gallardo, M.D.

9 a.m.-4 p.m.

CME Courses 86-90

10 a.m.-3 p.m.

APA Exhibit Open

Exhibits Open

Publishers Bookfair Open

11 a.m.-12:30 p.m.

Discussion Group 20. Larry B. Silver, M.D., on Clinical Management of ADHD With Children, Adolescents, and Adults (Meet the Authors)

Lectures

L21. Stress and Relapse to Substance Use Disorders: Kathleen T. Brady, M.D.; Collaborative Session With the National Institute on Drug Abuse; Distinguished Psychiatrist Lecture Series

L22. Public Academic Liaison: Pursuit of Best Practices in a Time of Economic Entrenchment: Peter F. Buckley, M.D., APA’s Administrative Psychiatry Award Lecture

Master Educator Clinical Consultations

10. James L. Griffith, M.D., on Engaging Patients’ Spiritual Resources in Building Resilience to Relapse of Major Psychiatric Disorders (Open to APA members only.)

11. Stephen M. Goldfinger, M.D., on Establishing Relationships, Enhancing Adherence, and Improving Outcomes (Open to APA members only.)

Medical Update 3. Richard P. Brown, M.D., on Better Sex: Naturally

Research Consultation 3. Jack M. Gorman, M.D., on Designing and Implementing Studies Contrasting Psychopharmacology and Psychotherapy

Scientific and Clinical Report Sessions

Session 19. Alcohol Abuse

56. The Effects of State Income Inequality and Alcohol Tax on Alcohol Dependence Claire Henderson, M.D.

57. Effect of Age on Long-Term Outcomes of Inpatient Alcoholism Treatment Neelofar Khan, M.D.

58. Topiramate Treatment of Alcohol Dependence: Effects on Psychosocial Functioning and Its Relationship With Heavy Drinking Bankole A. Johnson, M.D.

Session 20. Cross-Cultural Issues

59. Prevalence of Maternal Depression in Honduras Lawson R. Wulsin, M.D.

60. Screening for Depression Among Chinese Americans in Primary Care Using Two Items Albert Yeung, M.D.

61. Suicidal Thinking in Colombian Youth With a History of Attempted Suicide Ruby C. Castilla-Puentes, M.D.

Session 21. Suicide

62. Suicidality and Second-Generation Antipsychotics in Patients With Schizophrenia Yoram Barak, M.D.

63. Melancholia and Suicide Attempt Probability and Lethality Michael F. Grunebaum, M.D.

64. Nonviolent Suicides in Women Are Increased During and After High Exposure to Tree Pollen Teodor T. Postolache, M.D.

Session 22. Bipolar Disorder

65. Characteristics of Patients Treated With Gabapentin Referred to a Bipolar Specialty Clinic Michael J. Ostacher, M.D.

66. Olanzapine/Fluoxetine Combination: Rapid Onset With Low Risk of Mania Sara A. Corya, M.D.

67. Psychotic Features in MDD Are Associated With Mania Ekkehard Othmer, M.D.

Session 23. Biological Psychiatry

68. fMRI of Spatial Working Memory in Schizotypal Personality Disorder Harold W. Koenigsberg, M.D.

69. Hypofrontality in Patients With Schizophrenia and Bipolar Disorders: An fMRI Study Mircea C. Polosan, M.D.

70. Low Levels of Antibodies to Cardiolipin in First-Episode and Chronic Schizophrenia Pinkhas Sirota, M.D.

Session 24. Psychopharmacology Research in Depression

71. Prevalence of MTHFR C677T and Methionine Synthase A2756G Polymorphisms in Major Depression and Impact on Response to Fluoxetine Treatment David Mischoulon, M.D.

72. Oral S-Adensoyl Methionine (SAMe) for Antidepressant Augmentation: An Open-Label Trial Jonathan E. Alpert, M.D.

73. Somatic Symptoms as Predictors of Time to Onset of Response to Fluoxetine in MDD George I. Papakostas, M.D.

Session 25. Outcomes in Psychosis

74. IC-SOHO: Intercontinental Schizophrenia Outpatient Health Outcomes Study Martin Dossenbach, M.D.

75. Male Patients With Schizophrenia Have Impairment in the Processing of Spatial Information From Dissociated Spatial Reference Frames Miranda H. Chakos, M.D.

76. Predictors of Outcome in 52 Cases of Psychotic Nonaffective Disorders Mauricio F. Tohen, M.D.

Session 26. Substance Abuse Collaborative Session With the National Institute on Drug Abuse

77. Risk Factors for DSM-IV Cannabis Abuse and Dependence Jason P. Herrick, B.A.

78. Cannabis Use Reduces the Likelihood of Sustained Remission From Other Drugs Edward V. Nunes, M.D.

79. Substance-Induced Risk for Depression in a Substance-Dependent Population Rivka R. Galchen, M.D.

Session 27. Issues in Psychiatric Epidemiology

80. Ethnicity, Diagnosis, and Health Care Utilization in Incarcerated Women Catherine F. Lewis, M.D.

81. Psychotropic Drug Utilization in Six European Countries Giovanni De Girolamo, M.D.

82. Onset of DSM-IV Alcohol Abuse and Dependence: A 10-Year Prospective Study Deborah S. Hasin, Ph.D.

Component Workshops

CW42. Online Interaction Between APA, Members, and the Public APA Ad Hoc Work Group on Information Systems; Chairperson: Robert C. Hsiung, M.D.

CW43. Response to the Simon Bolivar Award Lecture on Latino Youth in the U.S.: Developmental and Mental Health Challenges APA Committee of Hispanic Psychiatrists; Co-Chairpersons: Ana E. Campo, M.D., Andres J. Pumariega, M.D.

CW44. Psychiatric Ethics in the U.S. and Throughout the World APA Ethics Committee; Co-Chairpersons: Spencer Eth, M.D., Driss Moussaoui, M.D.

CW45. The 2004 Medicare Update and Making the Most of the Carrier Advisory Committee APA Medicare Advisory Corresponding Committee; Chairperson: Edward Gordon, M.D.

CW46. Is There a Standard of Care for the Treatment of Dementia? APA Committee on Access and Effectiveness of Psychiatric Services for the Elderly; Chairperson: Allan A. Anderson, M.D.

CW47. Bend It Like Beckham: Asian Women, Achievements, and Cultural Conflicts APA Council on Global Psychiatry; Co-Chairpersons: Ramaswamy Viswanathan, M.D., Jacquelyn B. Chang, M.D.

CW48. Buprenorphine in the Trenches: What the General Psychiatrist Needs to Know APA Corresponding Committee on Training and Education in Addiction Psychiatry and APA Corresponding Committee on Treatment Services for Patients With Addictive Disorders; Co-Chairpersons: Marianne T. Guschwan, M.D., John A. Renner Jr., M.D.

Issue Workshops

IW104. Innovative Methods of Promoting Use of Evidence-Based Psychopharmacology Chairperson: David N. Osser, M.D.

IW105. When Psychiatrists Have Suffered a Mental Illness: Their Stories and Insights National Alliance for the Mentally Ill; Co-Chairpersons: Michael F. Myers, M.D., Leah J. Dickstein, M.D.

IW106. Will Outcomes Evaluation and Research Initiatives Save the Therapeutic Community? Chairperson: Gregory C. Bunt, M.D.

IW107. Negative-Symptom Spectrum Disorders: Response to Pharmacotherapy of Asperger’s Disorder Chairperson: Elizabeth Sirota, M.D.

IW108. Sometimes It Is About You: The Use of Self in Engaging and Treating Homeless Individuals Chairperson: Marvin A. Nierenberg, M.D.

IW109. Multiple Perspectives on the Pathological Fear Response: Integration of Psychotherapeutic and Psychopharmacologic Therapies Co-Chairpersons: David Steinman, M.D., Jennifer M. Bonovitz, Ph.D.

IW110. The Day I Died: A Near-Death Documentary and the Mind-Brain Barrier Chairperson: B. Jason MacLurg, M.D.

IW111. What Love Has to Do With It: Exploring the Role of Love in Mental Illness Co-Chairpersons: Robert W. Hierholzer, M.D., Bita Ghafoori, Ph.D.

IW112. Psychiatry and Homeland Security: An Exercise in Weapons of Mass Destruction Response Planning Co-Chairpersons: Larry H. Pastor, M.D., Dickson S. Diamond, M.D.

IW113. Fitness-for-Duty Evaluations for Law-Enforcement Officers Chairperson: Marilyn Price, M.D.

IW114. Evaluating Treatment With Functional Brain Imaging Co-Chairpersons: Daniel G. Amen, M.D., Joseph C. Wu, M.D.

IW115. Suicide and Schizophrenia: A Family Interview Chairperson: Paul A. Kettl, M.D.

IW116. Ethical and Practical Challenges in Emergency Psychiatric Research Co-Chairpersons: Rebecca W. Brendel, M.D., Melissa E. Abraham, Ph.D.

IW117. Developing a Community Mental Health Response to Disasters and Terrorism Co-Chairpersons: John W. Burruss, M.D., Jennifer E. Pate, M.D.

IW118. Juvenile-Justice Success Series, Chapter 1: Musicianship, Jazz, and Blues Chairperson: Cheryl D. Wills, M.D.

IW119. Politics and Pregnancy: The Regina McKnight Case Chairperson: Andrea G. Stolar, M.D.

Noon-1:30 p.m.

Forums

10. Buprenorphine: What the Clinician Should Know Chairperson: Herbert D. Kleber, M.D.

11. 9/11 Research: A Review and Reviews Chairperson: Anand Pandya, M.D.

Noon-2 p.m.

New Research Poster Session 8

1 p.m.-5 p.m.

CME Courses 91-97

2 p.m.-3:30 p.m.

Lectures

L23. The Brain in Love Helen E. Fisher, Ph.D.

L24. Striking Accord: Tales of Teaching and the Heart Eugene V. Beresin, M.D., APA/NIMH Vestermark Psychiatry Educator Award Lecture

2 p.m.-5 p.m.

Presidential Symposium 3. Reconstructing Postwar Mental Health Services World Psychiatric Association; Chairperson: Marcia Kraft Goin, M.D.; Co-Chairperson: Rodrigo A. Muñoz, M.D.

Symposia

S59. What You Need to Know About Treatment of HIV-Related Disorders

  A. Treating Mood Disorders Warren M. Liang, M.D.

  B. Treating Anxiety Antoine B. Douaihy, M.D.

  C. Treating Psychosis Shahrad Rod Amiri, M.D.

  D. Treating Sleep Marshall Forstein, M.D.

  E. Treating Pain Philip Bialer, M.D.

S60. Choosing the Best Treatment for Substance Abuse Collaborative Session With the National Institute on Drug Abuse

  A. Choosing the Right Treatment for Opioid Dependence Herbert D. Kleber, M.D.

  B. Choosing the Best Treatment for Cocaine Dependence Adam M. Bisaga, M.D.

  C. Choosing the Best Treatment: Marijuana and Club Drugs David M. McDowell, M.D.

  D. Treatment of Comorbid Conditions Frances R. Levin, M.D.

  E. Choosing the Best Treatment for Psychosocial Interventions Jami Rothenberg, Ph.D.

S61. Practical Techniques in the Assessment and Treatment of Tobacco Dependence Collaborative Session With the National Institute on Drug Abuse

  A. Assessment of Tobacco Dependence Jonathan Foulds, Ph.D.

  B. Motivational Assessment and Enhancement Strategies in Tobacco Treatment Jonathan Krejci, Ph.D.

  C. Pharmacotherapy Treatments for Tobacco Dependence Jill Williams, M.D.

  D. Psychosocial Treatment of Tobacco Dependence in Mental Health Settings Marc L. Steinberg, Ph.D.

  E. Addressing Tobacco Through Program and System Changes Douglas M. Ziedonis, M.D.

S62. Treatment-Resistant Depression

  A. Introduction to Treatment-Resistant Depression Charles B. Nemeroff, M.D.

  B. Long-Term Outcomes in Treatment-Resistant Depression A. John Rush, M.D.

  C. Introduction to a Treatment-Resistant Depression Patient Registry Martin B. Keller, M.D.

  D. Long-Term Treatment and Outcomes in Treatment-Resistant Depression With Pharmacotherapy, ECT, Repetitive Transcranial Magnetic Stimulation, MST, and VNS Therapy Thomas E. Schlaepfer, M.D.

S63. Psychotic Depression in 2004: The NIMH Collaborative Severe Depression Study

  A. Challenges in the Diagnosis of Psychotic Depression: Assessment, Epidemiology, and Biology Anthony J. Rothschild, M.D.

  B. Pharmacotherapy of Unipolar Major Depression: What Is the Evidence? Benoit H. Mulsant, M.D.

  C. NIMH Severe Depression Trial: Background and Design Choices Barnett S. Meyers, M.D.

  D. Challenges in Conducting a Pharmacotherapy Study in Psychotic Depression Alastair J. Flint, M.B.

  E. Real-Life Outcomes in Real-Life Patients: Discussion Barry D. Lebowitz, Ph.D.

S64. September 11: After Two-and-a-Half Years

  A. The First Two Weeks On Site Antonio Abad, M.D.

  B. New York State Office of Mental Health Response William M. Tucker, M.D.

  C. New York City Health and Mental Health: First Responders Neal L. Cohen, M.D.

  D. Disaster Psychiatry Outreach: Service and Training Craig L. Katz, M.D.

  E. Medical and Psychiatric Organizations and Findings Zebulon C. Taintor, M.D.

S65. Neuroimaging and Emotional Dysregulation in BPD

  A. Brain Imaging of Impulsivity and Affective Instability in BPD Larry J. Siever, M.D.

  B. Affect Regulation and BPD: fMRI and Daily Experience of Mood Katherine M. Putnam, Ph.D.

  C. Emotional Processing of Psychosocial Stimuli in BPD Jill M. Hooley, D.Phil.

  D. Investigation of Pain Processing in BPD Christian G. Schmahl, M.D.

  E. A PET Study of μ-Opioid Neurotransmission and Affective Lability in BPD Kenneth R. Silk, M.D.

S66. Diagnosing and Managing Aggressive Mood-Dysregulated Youth

  A. Parsing the Association Between Bipolar, Conduct, and Substance Use Disorders Joseph Biederman, M.D.

  B. A Family Genetic Perspective on Childhood Mania Stephen V. Faraone, Ph.D.

  C. Risperidone Treatment of Affective Symptoms in Mentally Retarded Youth With Conduct Disorder Eric Mick, Sc.D.

  D. Clinical Trials of a Mood Stabilizer for Aggressive, Mood-Dysregulated Youth Janet Wozniak, M.D.

  E. Collaborative Problem-Solving Therapy for Aggressive Youth Ross W. Greene, Ph.D.

  F. Anticonvulsants in the Management of Aggression in Youth Joseph M. Gonzalez-Heydrich, M.D.

S67. Residual Symptoms in Depression: Recognition and Treatment

  A. An Overview of Residual Symptoms in Depression Andrew A. Nierenberg, M.D.

  B. Sleep Disturbance as a Residual Symptom in Depression Matthew A. Menza, M.D.

  C. Anxiety as a Residual Symptom in Depression Alexander Bystritsky, M.D.

  D. Residual Sexual Dysfunction Associated With MDD and SSRI Treatment H. George Nurnberg, M.D.

  E. The Treatment of Residual Fatigue in Depression Humberto Marin, M.D.

S68. Women’s Mental Health Revisited: Current Perspectives, Future Trends Association of Women Psychiatrists

  A. Depression in the Reproductive Years Nada L. Stotland, M.D.

  B. Depression and Anxiety in Women in Late Life Marion Z. Goldstein, M.D.

  C. Domestic Violence: Its Impact Across the Life Cycle Leah J. Dickstein, M.D.

  D. PTSD in Women: Current Concepts and Treatments Marian I. Butterfield, M.D.

  E. Racism and Women’s Mental Health: The Intersection of Race and Gender Altha J. Stewart, M.D.

S69. Supportive Psychotherapy: An Update

  A. History of Supportive Psychotherapy Stephen Rojcewicz Jr., M.D.

  B. Role of Psychotherapy in the Management of Depression Michael E. Thase, M.D.

  C. Use of Supportive Psychotherapy With Bipolar Disorder Karen L. Swartz, M.D.

  D. Adapting Supportive Therapy for Treatment of BPD David J. Hellerstein, M.D.

  E. Development of Competencies in Supportive Therapy: Process and Problems Lisa A. Mellman, M.D.

S70. Anxiety Disorders in Youth: Clinical and Research Updates

  A. Evidence-Based Assessment Instruments With Children and Adolescents Thomas H. Ollendick, Ph.D.

  B. Pharmacological Treatment of Anxiety Disorder in Youth Marcia J. Slattery, M.D.

  C. Anxiety Disorders in Children and Adolescents: Are We Ready To Move Beyond the Study of Treatment Efficacy? Anne Marie Albano, Ph.D.

  D. A Cognitive Neuroscience Perspective on Childhood Anxiety Disorders Amy L. Krain, Ph.D.

S71. DSM-V Classification of Personality Disorders: The White Paper and Beyond

  A. Dimensional Models of Personality Disorder Thomas A. Widiger, Ph.D.

  B. Relationship of Personality Traits and Disorders to Axis I Disorders M. Tracie Shea, Ph.D.

  C. Axis I/Axis II Boundary: Spectrum Diseases and Molecular Neuroscience John H. Krystal, M.D.

  D. Temperament, Personality, and Personality Disorder: The Externalizing Spectrum Model Robert F. Krueger, Ph.D.

  E. The Neurobiology of Personality Traits: Focus on Aggression Emil F. Coccaro, M.D.

S72. Group Therapy in Medical/Psychiatric Care

  A. Group Therapy for Breast Cancer: Feeling and Healing David Spiegel, M.D.

  B. Impact of Group Therapy on Anticancer Treatment Adherence David W. Kissane, M.D.

  C. Mindfulness-Based Stress-Reduction Groups Susan E. Abbey, M.D.

  D. Psychiatrist-Led Group Psychotherapy for the Chronically Mentally Ill Leslie H. Gise, M.D.

  E. Group Therapy for Substance Abuse David W. Brook, M.D.

  F. Group Interventions for Psychological Trauma and Terrorism Henry I. Spitz, M.D.

S73. Dissociative Disorders: Issues of Culture and Issues of Trust Association for the Advancement of Philosophy and Psychiatry

  A. Diversity in Presentation of Dissociative Disorders in Turkey Vedat Sar, M.D.

  B. Differences Between Western and South African Models of Dissociation Christa Kruger, M.D.

  C. Dissociation, Trances, and Transcendence: Cultural Values and Their Effects on Trust Nancy L. Potter, Ph.D.

S74. Neuropsychiatry of Traumatic Brain Injury: Current Research American Neuropsychiatric Association

  A. The Cholinergic Hypothesis of Cognitive Impairment Due to Traumatic Brain Injury David B. Arciniegas, M.D.

  B. Catecholaminergic Dysfunction After Traumatic Brain Injury: Impact on Cognition Thomas McAllister, M.D.

  C. Traumatic Brain Injury, Gene Expression, and Risk for Schizophrenia Dolores Malaspina, M.D.

  D. Blast Injuries to the Brain: Armed Forces Injured During Operation Iraqi Freedom Deborah Lee Warden, M.D.

  E. Multicenter, Placebo-Controlled Trials in Traumatic Brain Injury: A Work in Progress Jonathan M. Silver, M.D.

S75. Psychiatry, Ethnicity, and Culture: An Update on Ethnopsychopharmacology, Mood, and Anxiety Disorders in Minority Populations

  A. Ethnopsychopharmacology Update David C. Henderson, M.D.

  B. Treatment of Anxiety and Depression Among Chinese Americans Albert Yeung, M.D.

  C. Psychiatric Management of Hispanic Patients: Cross-Cultural Issues and Ethnopsychopharmacology David Mischoulon, M.D.

  D. Depression and Anxiety in Women: An Update on Cross-Cultural Aspects and Pharmacologic Strategies Claudio N. Soares, M.D.

  E. Cultural Differences in the Diagnosis and Treatment of Mood and Anxiety Disorders: Considerations in the Asian-Indian Population Rajesh M. Parikh, M.D.

S76. Adopting Evidence-Based Practice in the Treatment of Mood Disorders: The Canadian Experience

  A. Treating Depression Effectively: Applying Clinical Guidelines Sidney H. Kennedy, M.D.

  B. Strategies to Enhance Mental Health Care in the Primary Care Sector: Working With Family Physicians Sagar V. Parikh, M.D.

  C. Evidence-Based Practice Leads to Improved Efficiency in the Work of a Specialized Mood-Disorders Service Roumen V. Milev, M.D.

  D. Translating Research Into Practice: The Application of Clinical Guidelines in Mood Disorders Valerie Taylor, M.D.

  E. Developing a Community-Based Strategy for Depression: The British Columbia Experience Raymond W. Lam, M.D.

S77. Impact of Trauma and Life Stress in Bipolar Disorder

  A. Psychosocial Stress and Vulnerability to Affective Relapse Michael J. Gitlin, M.D.

  B. Childhood Trauma and Outcome in Bipolar Patients Joseph F. Goldberg, M.D.

  C. Bipolar Disorder and the Family Environment David Miklowitz, Ph.D.

  D. Neurofunctional Correlates of Affective Stressors in Bipolar Patients Caleb M. Adler, M.D.

  E. Implications of the Kindling Model for Affective Relapse Robert M. Post, M.D.

S78. Gay and Lesbian Orthodox Jews: A Primer for Clinicians

  A. Orthodox Jewish Gays and Lesbians: The Filmmaker’s Perspective Sandi Dubowski

  B. Failed Reparative Therapy of Orthodox Jewish Homosexual Men and Women Abba E. Borowich, M.D.

  C. Identities in Conflict: Treating Gay and Lesbian Orthodox Jews Naomi Mark, M.S.W.

  D. Gayness and God: The Gay Orthodox Rabbi’s Perspective Steven Greenberg

S79. Personality, Therapeutic Alliance, and Outcome in Brief Psychotherapy

  A. Personality, Therapeutic Alliance, and Outcome in Short-Term Dynamic and Cognitive-Behavioral Psychotherapies Sarah Aderholt, M.D.

  B. Personality, Therapeutic Alliance, and Overall Outcome in Brief Relational Therapy Regina Biscoglio, M.A.

  C. Patient-Rated Alliance and Overall Outcome in Brief Psychotherapies Christopher Stevens, Ph.D.

  D. Therapist-Rated Alliance and Overall Outcome in Brief Psychotherapies Kevin Gillett

S80. Consequences and Treatment of Marijuana Abuse Collaborative Session With the National Institute on Drug Abuse

  A. Cognitive Toxicity of Cannabis: The Devil Is in the Confounding Variables Harrison G. Pope Jr., M.D.

  B. Cognitive Effects in Adolescents Exposed Prenatally to Marijuana or Cigarettes Peter A. Fried

  C. Effects of Chronic Marijuana Use and THC on Brain Function in Humans: A fMRI Study Alan S. Bloom, Ph.D.

  D. Behavioral and Treatment Research on Marijuana Withdrawal and Dependence Alan J. Budney, Ph.D.

  E. The Endogenous Cannabinoids and the Control of Drug Craving Daniele Piomelli, Ph.D.

S81. Personality Disorders: Multiple Perspectives in the Understanding and Treatment of Resistance

  A. Resistance in Personality Disorders From a Psychodynamic Perspective R. Rao Gogineni, M.D.

  B. Resistance in BPD: Cognitive-Behavioral Strategies That Facilitate Change Donna M. Sudak, M.D.

  C. Family Therapy With Personality Disorders G. Pirooz Sholevar, M.D.

  D. Clinical Practices That Lead to Treatment Resistance William R. Dubin, M.D.

S82. Clinical Controversies in ECT

  A. Controversies in ECT: Electrode Placement Conrad M. Swartz, M.D.

  B. Controversies in ECT: Stimulus Dosing W. Vaughn McCall, M.D.

  C. Controversies in ECT: Physiological Monitoring Charles H. Kellner, M.D.

  D. Denying Patients Treatments That Work William H. Reid, M.D.

S83. Toxic Love on Film: Romantic Love, From Normal to Pathologic

  A. Obsessive Love and the Loss of Self in Film Anton C. Trinidad, M.D.

  B. Using Films in the Teaching of Issues Around Romantic Love Robert J. Boland, M.D.

  C. Love: What Is Normal? Anton C. Trinidad, M.D.

S84. Moving the Targets: The Neurobiology of Addiction Collaborative Session With the National Institute on Drug Abuse

  A. Neuroadaptation in Addiction: The Extended Amygdala and Brain-Reward System George F. Koob, Ph.D.

  B. Neural Circuitry of Relapse Peter W. Kalivas, Ph.D.

  C. Drugs, Neuroplasticity, and Addiction Terry E. Robinson, Ph.D.

  D. How Do Drugs of Abuse Rewire the Motivational Circuitry? Marina E. Wolf, Ph.D.

S85. Drug Abuse Treatment Issues in Women Collaborative Session With the National Institute on Drug Abuse

  A. Gender Differences in Treatment Needs, Services, Utilization, and Outcomes Karol A. Kaltenbach, Ph.D.

  B. Treatment Issues in Drug-Dependent Women With Comorbid Depression Rajita Sinha

  C. Trauma and PTSD: Issues in the Treatment of Drug-Dependent Women Denise Hien, Ph.D.

  D. Drug-Dependent Women With Partner Violence: Treatment Issues Brenda A. Miller, Ph.D.

  E. Drug-Treatment Issues in Drug-Dependent, Pregnant Women Hendree Jones, Ph.D.

S86. Managing HIPAA-Related Tensions in Clinical Practice

  A. Intended and Actual Effects of HIPAA on Clinical Practice Claudette H. Beahrs, M.S.W.

  B. The Impact of HIPAA on Psychiatric Hospital Care: The Good, the Bad, and the Ugly Steven S. Sharfstein, M.D.

  C. Regulation, HIPAA, and the Quest for Optimum Constraint John O. Beahrs, M.D.

  D. Complying With HIPAA Made Less Difficult Jeffrey L. Metzner, M.D.

S87. Memory in the U.S. and France: Vive La Difference

  A. What Can We Learn From the False-Memory Wars? Paul R. McHugh, M.D.

  B. PTSD: Too Much or Too Little Memory? Anne-Marie F. Pezous, M.D.

  C. The Nature of Traumatic Memory: Implications for Treatment Bessel A. Van Der Kolk, M.D.

  D. Depression and Dementia: Looking for Specific Memory Impairments Eric Fakra, M.D.

  E. Cognitive Impairment in Late-Life Depression Charles F. Reynolds III, M.D.

  F. Depression: Remembering the Bad Things Natacha Fouilhoux, M.D.

S88. Quality of Care for Children: Multiple Perspectives

  A. Quality of Care From the Agency’s Perspective: Are Medicaid Claims Data Valid? Penelope Knapp, M.D.

  B. Quality of Care for Children in Outpatient Mental Health Programs Bonnie T. Zima, M.D.

  C. Unraveling Variations in Access to ADHD Care: Deductive Analysis Findings Regina Bussing, M.D.

  D. Quality Improvement of Mental Health Services for Children in Special Education Sheryl H. Kataoka, M.D.

S89. Meeting the Mental Health Needs of Latinos in Community and Primary Care

  A. PTSD in Latinos: Reactions in Primary Care to the World Trade Center Attacks Yuval Y. Neria, Ph.D.

  B. Depression and Diabetes in an Urban General Medicine Clinic Raz Gross, M.D.

  C. Bipolar Spectrum Disorder in Hispanic Primary Care Patients Amarendra Das, M.D.

  D. Disparities in Mental Health Treatment for Latinos in Community Care William Vega

2 p.m.-5:30 p.m.

Review of Psychiatry (Section 4): Brain Stimulation in Psychiatric Treatment Chairperson: Sarah H. Lisanby, M.D.

16. Transcranial Magnetic Stimulation in Depression Thomas E. Schlaepfer, M.D.

17. Transcranial Magnetic Stimulation Studies of Schizophrenia and Other Disorders Ralph E. Hoffman, M.D.

18. Deep Brain Stimulation in Psychiatry Benjamin D. Greenberg, M.D.

19. Vagus Nerve Stimulation in Psychiatry Harold A. Sackeim, Ph.D.

20. Magnetic Seizure Therapy: Development of a Novel Convulsive Technique Sarah H. Lisanby, M.D.

3 p.m.-5 p.m.

New Research Poster Session 9

7 p.m.-10 p.m.

Industry-Supported Symposia

IS52. Optimizing Antipsychotic Treatment in Patients With Schizophrenia and Bipolar Disorder Supported by Bristol-Myers Squibb Company

  A. Optimizing Pharmacotherapy for Maximized Outcomes Alan J. Mendelowitz, M.D.

  B. Keeping Tolerability in Mind: Ensuring Adherence to Maintain Recovery Henry A. Nasrallah, M.D.

  C. Finding Effectiveness Across Patient Age Groups Rajiv Tandon, M.D.

  D. Balancing the Efficacy and Tolerability for Pediatric Bipolar Disorder Melissa P. DelBello, M.D.

  E. Treatment Considerations in Special Populations: Sex Differences Diana O. Perkins, M.D.

IS53. Core Symptom Domains in the Anxiety Disorders Supported by Wyeth Pharmaceuticals

  A. Differential Diagnosis and Biology of Panic and GAD Jack M. Gorman, M.D.

  B. Symptoms and Biologic Correlates of PTSD: From Early Adulthood to Old Age Rachel Yehuda, Ph.D.

  C. The Social Anxiety Spectrum Michael R. Liebowitz, M.D.

  D. The Repetitive Behavior Domain in Obsessive-Compulsive and Developmental Disorders Eric Hollander, M.D.

  E. Mixed Anxiety and Depression: A Gordian Knot Joseph Zohar, M.D.

IS54. Back to the Future: The Role of Gamma-Aminobutyric Acid in Psychiatric Disorders and Treatment Supported by Cephalon Inc.

  A. Gamma-Aminobutyric Acid in the CNS Philip T. Ninan, M.D.

  B. Neuroimaging and Anxiety Justine M. Kent, M.D.

  C. Gamma-Aminobutyric Acidergic Agents in Anxiety Treatment: A Look Back and Ahead Mark H. Pollack, M.D.

  D. Emerging Gamma-Aminobutyric Acidergic Targets for Insomnia John W. Winkelman, M.D.

  E. Beyond Anxiety Disorders: The Role of Gamma-Aminobutyric Acid in Mood Disorders Naomi M. Simon, M.D. ▪